Hallmarks of Cancer Cell

The fascinating complexity of a cancer cell is derived collectively from six basic alterations of cell physiology that result in sustained malignant proliferation (Hanahan and Weinberg 2000). However in in vitro cancer cells, four of the variations are easily detectable in yielding a phenotype of persistent proliferation and aversion from apoptosis. Cell migration/metastasis and angiogenesis are the other two which may be only observed in vivo. Genetic mutations in proto-oncogenes, onco-suppressors, and environmental conditions like hypoxia or inflammation contribute to malignant growth. The loss of tumor suppressor genes (TSG) by mutation may contribute to uncontrolled cell growth leading to cancer. Similarly proto-oncogenes are active in the signaling pathway for cell growth, and on mutation they transform into oncogenes triggering nonstop cell divisions leading to hyper-proliferation. Data implies that tumor cells are different from normal cells in at least six ways relating to growth control: sustaining proliferative signaling, evading growth suppressors, resisting cell death, inducing angiogenesis, invading replicative immortality, and activating invasion and metastasis (Hanahan and Weinberg 2011) (Fig. 2.1).

[1]  N. Ferrara Vascular Endothelial Growth Factor , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[3]  G. Evan,et al.  p53 — a Jack of all trades but master of none , 2009, Nature Reviews Cancer.

[4]  C. Sonnenschein,et al.  The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique , 2013, Journal of Biosciences.

[5]  Sven Diederichs,et al.  The hallmarks of cancer , 2012, RNA biology.

[6]  Alberto Mantovani,et al.  Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. , 2009, Carcinogenesis.

[7]  A. Celeghin,et al.  Epstein-Barr virus and telomerase: from cell immortalization to therapy , 2014, Infectious Agents and Cancer.

[8]  D. Sabatini,et al.  Cancer Cell Metabolism: Warburg and Beyond , 2008, Cell.

[9]  M. Blasco Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.

[10]  J. Bartek,et al.  The DNA-damage response in human biology and disease , 2009, Nature.

[11]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[12]  T. Chan,et al.  Frequent somatic TERT promoter mutations in thyroid cancer: higher prevalence in advanced forms of the disease. , 2013, The Journal of clinical endocrinology and metabolism.

[13]  Amit Verma,et al.  Cancer biomarkers - current perspectives. , 2010, The Indian journal of medical research.

[14]  J. Schlessinger,et al.  Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.

[15]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[16]  Frederick A. Dick,et al.  Molecular mechanisms underlying RB protein function , 2013, Nature Reviews Molecular Cell Biology.

[17]  D. Sabatini,et al.  Cancer cell metabolism: one hallmark, many faces. , 2012, Cancer discovery.

[18]  Tomas Lindahl,et al.  Repair and genetic consequences of endogenous DNA base damage in mammalian cells. , 2004, Annual review of genetics.

[19]  Russell G. Jones,et al.  Tumor suppressors and cell metabolism: a recipe for cancer growth. , 2009, Genes & development.

[20]  D. Lane,et al.  p53, guardian of the genome , 1992, Nature.

[21]  J. Geschwind,et al.  Tumor glycolysis as a target for cancer therapy: progress and prospects , 2013, Molecular Cancer.

[22]  G. Berx,et al.  Involvement of members of the cadherin superfamily in cancer. , 2009, Cold Spring Harbor perspectives in biology.

[23]  G. Semenza HIF-1: upstream and downstream of cancer metabolism. , 2010, Current opinion in genetics & development.

[24]  L. Coussens,et al.  Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity , 2010, Cancer and Metastasis Reviews.

[25]  H. Dvorak,et al.  Heterogeneity of the Tumor Vasculature , 2010, Seminars in thrombosis and hemostasis.

[26]  Y. Shyr,et al.  Transforming Growth Factor-β Signaling–Deficient Fibroblasts Enhance Hepatocyte Growth Factor Signaling in Mammary Carcinoma Cells to Promote Scattering and Invasion , 2008, Molecular Cancer Research.

[27]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[28]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[29]  Marius Raica,et al.  Angiogenesis in pre-malignant conditions. , 2009, European journal of cancer.

[30]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[31]  D. Peeper,et al.  The essence of senescence. , 2010, Genes & development.

[32]  R. DePinho,et al.  Telomeres and telomerase in cancer. , 2010, Carcinogenesis.

[33]  T. Halazonetis,et al.  Genomic instability — an evolving hallmark of cancer , 2010, Nature Reviews Molecular Cell Biology.

[34]  A. Velez,et al.  Tumor-suppressor Genes, Cell Cycle Regulatory Checkpoints, and the Skin , 2015, North American journal of medical sciences.

[35]  C. Vajdic,et al.  Cancer incidence and risk factors after solid organ transplantation , 2009, International journal of cancer.

[36]  D. Feldser,et al.  Short telomeres limit tumor progression in vivo by inducing senescence. , 2007, Cancer cell.

[37]  R. Schreiber,et al.  Immune‐mediated dormancy: an equilibrium with cancer , 2008, Journal of leukocyte biology.

[38]  Yosef Yarden,et al.  Roles for growth factors in cancer progression. , 2010, Physiology.

[39]  M. Esteller,et al.  Aberrant epigenetic landscape in cancer: how cellular identity goes awry. , 2010, Developmental cell.

[40]  Varda Rotter,et al.  Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. , 2011, Genes & cancer.

[41]  S. Cory,et al.  The Bcl-2 apoptotic switch in cancer development and therapy , 2007, Oncogene.

[42]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[43]  J. Wischhusen,et al.  Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape? , 2014, Front. Immunol..

[44]  G. Saretzki,et al.  DNA damage in telomeres and mitochondria during cellular senescence: is there a connection? , 2007, Nucleic acids research.

[45]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[46]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2014 .